-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Anti-tumor drugs are a hot spot in the research and development of innovative drugs in the world.
The time limit for soliciting opinions is 30 days from the date of publication
Please send your feedback to the mailbox of the following contact:
Contact: Wang Yuzhu, Gao Lili
Contact: wangyzh@cde.
Thank you for your participation and great support
Drug Evaluation Center of the State Drug Administration
August 3, 2021
Attachment 1: "Technical Guidelines for the Expansion of Cohort Studies in the First Human Trials of Antitumor Drugs (Draft for Comment)".
"Guiding Principles for the Expansion of Cohort Studies in the First Human Trial of Antitumor Drugs (Draft for Comment)".
Drafting Instructions for "Expanded Cohort Study Technical Guidelines for the First Human Trial of Antitumor Drugs (Draft for Comment)".
"Guiding Principles for the Expansion of Cohort Studies in the First Human Trial of Antitumor Drugs (Draft for Comment)" feedback form.
docx